Advanced cellular therapies are transforming the treatment of cancer and autoimmune diseases, but scientific breakthroughs alone are not enough. Delivering these therapies requires specialized infrastructure, advanced manufacturing capabilities, multidisciplinary expertise, and continuous research. At a time when many European patients face limited access to these treatments, Sheba has built one of the world's most comprehensive cellular therapy programs.